Ride Health and ACTIV-2 Partner to Provide Transportation for Nationwide COVID-19 Therapeutic Study

Ride Health and ACTIV-2 Partner to Provide Transportation for Nationwide COVID-19 Therapeutic Study

NIH-funded Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-2) study leveraging company’s COVID-19 equipped transportation network across dozens of sites nationwide

See more here

Comments are closed.